A Lipidomics Study Reveals Lipid Signatures Associated with Early Allograft Dysfunction in Living Donor Liver Transplantation

Liver transplantation has become the ultimate treatment for patients with end stage liver disease. However, early allograft dysfunction (EAD) has been associated with allograft loss or mortality after transplantation. We aim to utilize a metabolomic platform to identify novel biomarkers for more acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hsin-I, Lo, Chi-Jen, Zheng, Chih-Wen, Lee, Chao-Wei, Lee, Wei-Chen, Lin, Jr-Rung, Shiao, Ming-Shi, Cheng, Mei-Ling, Yu, Huang-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352109/
https://www.ncbi.nlm.nih.gov/pubmed/30597989
http://dx.doi.org/10.3390/jcm8010030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352109/
https://www.ncbi.nlm.nih.gov/pubmed/30597989
http://dx.doi.org/10.3390/jcm8010030

Ejemplares similares